Abstract:Patient-reported outcomes (PROs), which provide a direct measure of a patient's health status or treatment preferences, represent a key component of the shift toward patient-centered health care. PROs can measure the state of a patient's disease-specific and overall health throughout the care continuum, enabling them to have a variety of uses for key health care stakeholders. Currently, PROs are used in drug development, aligning patient and clinician goals in care, quality-of-care measures, and coverage and reimbursement decisions. While there have been significant strides by key health care stakeholders to further the development and use of PROs, there are a number of challenges limiting more widespread use. In light of these current challenges and the potential for PROs to improve health care quality and value, on October 19, 2017, the Academy of Managed Care Pharmacy convened a forum of key stakeholders representing patients, payers, providers, government, and pharmaceutical companies to discuss and identify solutions to the current challenges and barriers to further use of PROs. These discussions informed the development of participants' ideal future state in which PROs maximize the goals of all health care stakeholders and the actionable steps required to make the future state a reality. While stakeholders shared unique perspectives throughout the forum, they had consensus on 2 overarching issues: the importance of PROs in defining value, improving patient care, and implementing value-based payment models and the need for strong organizational and operational systems to achieve optimal adoption and use. Participants identified several key challenges in PRO use and adoption: achieving a representative patient population, inclusion of PRO data in medication labels, the necessity for both standardized and customizable PROs, and operational and organizational barriers to collecting and analyzing PROs. To overcome these challenges, participants recommended that manufacturers should engage key stakeholders early and throughout the drug development process to ensure the most valid and representative PROs and patient populations will be included. To streamline the PRO collection process, participants suggested engaging pharmacists and other providers who may have more frequent interaction with patients. Participants also recommended that PRO collection and analysis should use common technology platforms, streamline components of clinician care to reduce workflow, and be integrated with claims data to provider payers a better understanding of patient health in real time. Finally, additional work should be done to develop patient-reported outcome measures that contain relevant measures for all healthcare stakeholders. While significant challenges remain in PRO development and adoption, participants agreed that greater use can only be achieved through collaboration and patient-centered care. Disclosures: The AMCP Partnership Forum titled "Improving Quality, Value, and Outcomes with Patient-Reported Outcomes" and the development of this proceedings report were supported by Amgen, Boehringer Ingelheim Pharmaceuticals, Genentech, GlaxoSmithKline, Novartis Pharmaceuticals, Novo Nordisk, Precision for Value, Premier, Sanofi, Takeda Pharmaceuticals USA, and Xcenda.

Oh, the places we’ll go: patient-reported outcomes and electronic health records

Planning for Patient-Reported Outcome Implementation: Development of Decision Tools and Practical Experience Across Four Clinics

A framework for implementing patient-reported outcomes in clinical care: the PROTEUS-practice guide

The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy

Patient Experience and Attitudes Toward Electronic Intake and Patient-Reported Outcomes Within an Outpatient Whole Health Center

Seamless Integration of Computer-Adaptive Patient Reported Outcomes into an Electronic Health Record

Patient-reported outcomes (PROs): putting the patient perspective in patient-centered outcomes research

Measure once, cut twice—adding patient-reported outcome measures to the electronic health record for comparative effectiveness research

Clinic-based perspectives on the integration of patient-reported outcomes (PROs) in a tertiary cancer center

Strategies for implementing an electronic patient-reported outcomes-based symptom management program across six cancer centers

Perceived Barriers Toward Patient-Reported Outcome Implementation in Cancer Care: An International Scoping Survey

A mixed methods evaluation of patient perspectives on the implementation of an electronic health record-integrated patient-reported symptom and needs monitoring program in cancer care

Issues in the design of Internet-based systems for collecting patient-reported outcomes

Methods for developing patient-reported outcome-based performance measures (PRO-PMs)

MSK Engage: A comprehensive program for collection of patient reported outcomes at scale.

Learning to Overcome Barriers to Electronic Patient-Reported Outcome Implementation: Lessons From the Field

Patient-reported outcome performance measures in oncology

AMCP Partnership Forum: Improving Quality, Value, and Outcomes with Patient-Reported Outcomes

Implementation of Patient Engagement Tools in Electronic Health Records to Enhance Patient-Centered Communication: Protocol for Feasibility Evaluation and Preliminary Results

Automating Patient-reported Data Collection: Does it Work?

Feedback of aggregate patient-reported outcomes (PROs) data to clinicians and hospital end users: findings from an Australian codesign workshop process